期刊文献+

人mcl1不同亚型在结肠癌组织中表达变化的临床意义 被引量:1

Clinical Significance of Different Human mcl1 Subtypes Expression in Colorectal Cancer Tissues
下载PDF
导出
摘要 目的探讨人mcl1基因不同亚型在结肠癌组织中差异表达的临床意义。方法采用RT-PCR和Western blot分别检测正常结肠组织、结肠腺瘤、结肠腺癌组织以及相应的癌旁组织各20例中mcl1基因三种m RNA剪接异构体和三种蛋白亚型的表达水平,进而分析这些亚型表达差异与肿瘤临床病理特征之间的相关性。结果 mcl1基因亚型1在结肠肿瘤组织及相应旁组织中的m RNA和蛋白质水平表达均高于正常组(P=0.009,P=0.022),且腺癌组中的m RNA和蛋白质水平表达亦高于腺瘤组(P=0.004,P=0.034)。亚型2在结肠肿瘤组织及对应旁组织中的m RNA和蛋白质水平表达均高于正常组(P=0.002,P=0.011),且腺癌组中的m RNA和蛋白质水平表达亦高于腺瘤组(P<0.001,P=0.007)。亚型3在结肠肿瘤组织及对应旁组织中的m RNA和蛋白质水平表达均高于正常组(P=0.027,P=0.045),但肿瘤组与相应旁组织之间以及腺癌组与腺瘤组之间的比较差异均无统计学意义。结论研究表明mcl1亚型1和亚型2对结肠癌肿瘤恶性程度呈正相关,可以作为临床评估结肠癌恶性程度有效的诊断指标之一。而亚型3可以作为肿瘤早期诊断的标志物,但其表达水平与恶性程度无明显相关性。 Objective To investigate the clinical significance of differential human mcll subtypes expression in colorectal cancer tissues. Methods The differential expression of three mRNA splicing variants and protein subtypes of mcll were detected in each 20 cases of normal colon tissues, eolorectal adenoma, colorectal adenocarcinoma and their relative para-carcinoma tissues using RT-PCR and Western blot, and then we further analyzed the relationship of these variants expression with clinicopathological characteristics in the colon tumors. Results The expression of subtypes 1 and 2 of mcll were higher in colon tumor tissues and relative para-carcinoma tissues than those in normal control, and higher in the adenocarcinoma tissues than those in adenoma tissues. The expression of subtype 3 of reel 1 were higher in colon tumor tissues and relative para-carcinoma tissues than those in normal control, but no statistical significance in the comparison between tumor tissues and their relative para-carcinoma tissues as well as the comparison between adenocarcinoma tissues and adenoma tissues. Conclusion The subtypes 1 and 2 of mcll expression are demonstrated as a positive correlation with the malignancy level of colon tumor and could be used as efficient biomarkers in clinical diagnosis. The subtypes 3 could be used as an early biomarker for colon tumor diagnosis, while its expression has no significant correlation with the malignancy level of colon tumor.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2016年第2期141-145,共5页 Cancer Research on Prevention and Treatment
基金 国家自然科学基金青年科学基金项目(81300113)
关键词 结肠癌 mcl1 亚型 RNA剪接异构体 蛋白亚型 Colon cancer mcll Subtypes RNA splicing variants Protein variants
  • 相关文献

参考文献15

  • 1Tárraga López PJ, Albero JS, Rodríguez-Montes JA. Primary and secondary prevention of colorectal cancer[J]. Clin Med Insights Gastroenterol, 2014, 7: 33-46. 被引量:1
  • 2赵燕,沈晓云.Mcl-1蛋白的抗凋亡作用与癌症治疗[J].生命的化学,2011,31(6):863-867. 被引量:2
  • 3Bingle CD, Craig RW, Swales BM, et al. Exon skipping in Mcl-1 results in a bcl-2 homology domain 3 only gene product that promotes cell death[J]. J Biol Chem, 2000, 275(29): 22136-46. 被引量:1
  • 4Jamil S, Sobouti R, Hojabrpour P, et al. A proteolytic fragment of Mcl-1 exhibits nuclear localization and regulates cell growth by interaction with Cdk1[J]. Biochem J, 2005, 398(Pt 3): 659-67. 被引量:1
  • 5Kitada S, Andersen J, Akar S, et al. Expression of apoptosisregulating proteins in chronic lymphocytic leukemia: Correlations with in vitro and in vivo chemoresponses[J]. Blood, 1998, 91(9):3379-89. 被引量:1
  • 6Taniai M, Grambihler A, Higuchi H, et al. MCL-1 mediates tumor necrosis factor-related aptoptosis-indcing ligand resistance in human cholangicarcinoma cells[J]. Cancer Res, 2004, 64(10):3517-24. 被引量:1
  • 7张叶..eIF3a,mcl-1和CD83在结肠癌组织和血清中的表达及其临床病理意义[D].苏州大学,2014:
  • 8Germain M, Duronio V. The N terminus of the anti-apoptotic BCL-2 homologue MCL-1 regulates its localization and function [J]J Biol Chem, 2007, 282(44): 32233-42. 被引量:1
  • 9Song L, Coppola D, Livingaton S, et al. Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells[J]. Cancer Biol Ther, 2005, 4(3): 267-76. 被引量:1
  • 10Schulze-Bergkamen H, Flerscher B, Schuchmann M, et al. Suppression of mcl-1via RNA interference sensitizes human heaptocellular carcinoma cells towards apoptosis induction[J].BMC Cancer, 2006, 6: 232. 被引量:1

二级参考文献49

  • 1马向涛,王杉,杜如昱,叶颖江,崔志荣.Stat3反义寡核苷酸联合化疗调控结肠癌细胞增殖与凋亡的分子机制[J].中华实验外科杂志,2004,21(10):1212-1214. 被引量:25
  • 2Clohessy JG et al. Mcl-I interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor- mediated apoptosis. JBiol Chem, 2006, 281 : 5750-5759. 被引量:1
  • 3Green DR et al. Mitochondria and apoptosis. Science, 1998, 281: 1309-1312. 被引量:1
  • 4Rahmani Met al. Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation. J Biol Chem, 2005, 280: 35217-35227. 被引量:1
  • 5Bain Jet al. The specificities of protein kinase inhibitors: an update. Biochem J, 2003, 371 : 199-204. 被引量:1
  • 6Kane RC et al. Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy. Oncologist, 2003, 8:508-513. 被引量:1
  • 7Kane RC et al. Bortezomib for the treatment of mantle cell lymphoma. Clin Cancer Res, 2007, 13:5291-5294. 被引量:1
  • 8Kane RC et al. Sorafenib for the treatment of advanced renal cell carcinoma. Clin Cancer Res, 2006, 12:2955-2960. 被引量:1
  • 9Chen S et al. Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation. Cancer Res, 2007, 67:782-791. 被引量:1
  • 10Rosato RR et al. The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation. Cancer Res, 2007, 67: 9490- 9500. 被引量:1

共引文献19

同被引文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部